Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Strata Skin Sciences's Return On Capital Employed Insights

Strata Skin Sciences (NASDAQ:SSKN) brought in sales totaling $9.06 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 62.96%, resulting in a loss of $849.00 thousand.

Benzinga

UroGen Pharma's Return On Capital Employed Overview

According to data from Benzinga Pro, during Q4, UroGen Pharma's (NASDAQ:URGN) reported sales totaled $16.17 million. Despite a 5.82% increase in earnings, the company posted a loss of $28.45 million.

Benzinga

Here's Why BTIG Is Bullish On Datadog

BTIG analyst Gray Powell initiated coverage of Datadog Inc (NASDAQ:DDOG) with a Buy rating and $175 price target (24.9% upside). Powell saw the observability market benefiting over the next few years as companies increasingly invest in digital transformation initiatives. Powell saw Datadog "winning across multiple product categories." Powell's checks indicate Datadog as the most innovative…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Helbiz Media Inks Deal To Distribute Helbiz Live On Amazon Video In Italy

Helbiz Inc's (NASDAQ:HLBZ) Helbiz Live will be available on Amazon.Com Inc (NASDAQ:AMZN) Amazon Prime Video Channels on April 2, after the recent completion of technology integration. Helbiz Media and Amazon Prime Video have signed an agreement to distribute Helbiz Live on Amazon Video in Italy. HelbizLive is Italy's new live sports streaming service and home of…

Benzinga

Bernstein Explains How Apple Could Produce $10B In Incremental Revenue

Bernstein analyst Toni Sacconaghi acknowledged that Apple Inc (NASDAQ: AAPL) had quietly built a small but growing ad business. However, Sacconaghi estimated that Apple's ad revenue was well under 2% of its overall revenue.

Benzinga

Adamis Pharma Recalls Allergy Treatment Symjepi For Potential Manufacturing Defect

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) voluntarily recalls certain lots of Symjepi (epinephrine) Injection 0.15 mg and 0.3 mg pre-filled single-dose syringes to the consumer level. The batches are being recalled due to the potential clogging of the needle preventing the dispensing of epinephrine. US WorldMeds (USWM) exclusively markets and distributes Symjepi in the U.S.,…

Benzinga

Why Okta Shares Are Tumbling Today

Okta Inc (NASDAQ: OKTA) shares are trading lower Tuesday morning following several reports indicating the company is investigating a digital breach.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

What 5 Analyst Ratings Have To Say About Upstart Hldgs

Within the last quarter, Upstart Hldgs (NASDAQ:UPST) has observed the following analyst ratings:

Benzinga

Expert Ratings For Coinbase Global

Within the last quarter, Coinbase Global (NASDAQ:COIN) has observed the following analyst ratings:

Benzinga

Looking Into Spartannash Company's Recent Short Interest

Spartannash Company's (NASDAQ:SPTN) short percent of float has risen 3.59% since its last report. The company recently reported that it has 2.32 million shares sold short, which is 6.64% of all regular shares that are available for trading.

Benzinga

Psyched: MindCure Shuts Down Operations, Novamind And MindMed Partner For Study

The psychedelics space was shaken up on the news that MindCure Health (OTC:MCURF) was shutting down operations. After a review process, the company’s board decided that MindCure’s business plan required more capital that it could gather under current market conditions, thus shutting down operations was considered the best move to preserve…

Benzinga

Analyzing Marinus Pharmaceuticals Inc's Short Interest

Marinus Pharmaceuticals Inc's (NASDAQ:MRNS) short percent of float has risen 9.74% since its last report. The company recently reported that it has 1.23 million shares sold short, which is 3.83% of all regular shares that are available for trading.

Benzinga

AC Immune: Q4 Earnings Insights

AC Immune (NASDAQ:ACIU) reported its Q4 earnings results on Tuesday, March 22, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings AC Immune reported an EPS of $-0.28.

Benzinga

10 Industrials Stocks Moving In Tuesday's Pre-Market Session

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga's Daily Brief On Trending Tickers For March 22, 2022: Alibaba, Nike, Tesla And More

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks. The data on the trending tickers is compiled from a list of most-discussed tickers on the popular Reddit forum WallStreetBets.

Benzinga

12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session

Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga

12 Information Technology Stocks Moving In Tuesday's Pre-Market Session

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why Bitcoin- And Ethereum-Related Stocks Are Trading Higher

Cryptocurrency-related stocks, including Marathon Digital Holdings Inc (NASDAQ: MARA) Riot Blockchain Inc (NASDAQ: RIOT) and Bitfarms Ltd (NASDAQ:

Benzinga

Why Jim Cramer Likes Truist Financial

On CNBC’s "Mad Money Lightning Round," Jim Cramer said PPG Industries, Inc. (NYSE: PPG) shares are down too much as the company has been hurt by raw costs, but that’s going to end finally.

Benzinga

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Why Upstart Shares Are Trading Lower Today

Upstart Holdings, Inc. (NASDAQ: UPST) shares are trading lower after Wedbush downgraded the stock from Neutral to Underperform and lowered its price target from $110 to $75.

Benzinga

Morning Brief: Top Stories Dominating Financial Media on Tuesday, March 22

CNBC

Benzinga

Central Banks, Bank For International Settlements Develop Digital Currencies Platform Prototype

Central banks are trying to come to terms with emerging payment technologies pioneered by tech firms. Meta Platform Inc's (NASDAQ:

Benzinga

Cannabis Industry Lender Chicago Atlantic Real Estate Finance Reports Q4 Net Income Of $4.4M On Heels Of IPO

Cannabis-focused mortgage REIT Chicago Atlantic Real Estate Finance, Inc. (NASDAQ:REFI) has reported its financial results for the fourth quarter and period ended December 31, 2021.

1 … 848 849 850 851

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

349 stories

Merck

309 stories

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.